Barclays PLC Compugen LTD Transaction History

Barclays PLC

$327 Billion
Q2 2024

A detailed history of Barclays PLC transactions in Compugen LTD stock. As of the latest transaction made, Barclays PLC holds 560 shares of CGEN stock, worth $918. This represents 0.0% of its overall portfolio holdings.

Number of Shares

560

Previous 1,297 56.82%

Holding current value

$918

Previous $4,000 100.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.68 - $2.52 $1,238 - $1,857	-737 Reduced 56.82%	560 $0
Q4 2023 Feb 15, 2024	BUY	$0.53 - $2.0 $372 - $1,406	703 Added 118.35%	1,297 $2,000
Q3 2023 Nov 07, 2023	BUY	$0.88 - $1.31 $261 - $389	297 Added 100.0%	594 $0
Q2 2023 Aug 03, 2023	SELL	$0.57 - $1.38 $570 - $1,380	-1,000 Reduced 77.1%	297 $0
Q4 2022 Feb 13, 2023	SELL	$0.58 - $1.2 $3,292 - $6,811	-5,676 Reduced 81.4%	1,297 $1,000
Q3 2022 Nov 03, 2022	SELL	$0.66 - $2.32 $10,048 - $35,322	-15,225 Reduced 68.59%	6,973 $5,000
Q2 2022 Aug 12, 2022	BUY	$1.57 - $3.33 $31,710 - $67,259	20,198 Added 1009.9%	22,198 $41,000
Q1 2022 May 16, 2022	SELL	$2.76 - $4.64 $259 - $436	-94 Reduced 4.49%	2,000 $6,000
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $46,904 - $82,110	-11,468 Reduced 84.56%	2,094 $9,000
Q3 2021 Nov 09, 2021	BUY	$5.8 - $8.02 $29,139 - $40,292	5,024 Added 58.84%	13,562 $80,000
Q2 2021 Aug 13, 2021	SELL	$6.87 - $9.16 $59,549 - $79,398	-8,668 Reduced 50.38%	8,538 $71,000
Q1 2021 May 13, 2021	SELL	$7.67 - $13.77 $230,560 - $413,926	-30,060 Reduced 63.6%	17,206 $147,000
Q4 2020 Feb 11, 2021	SELL	$12.07 - $17.95 $46,469 - $69,107	-3,850 Reduced 7.53%	47,266 $572,000
Q3 2020 Nov 12, 2020	BUY	$14.16 - $19.45 $17,218 - $23,651	1,216 Added 2.44%	51,116 $831,000
Q2 2020 Aug 12, 2020	BUY	$6.97 - $17.12 $227,919 - $559,824	32,700 Added 190.12%	49,900 $749,000
Q1 2020 May 13, 2020	BUY	$5.79 - $11.83 $98,696 - $201,654	17,046 Added 11068.83%	17,200 $125,000
Q4 2019 Feb 10, 2020	BUY	$3.9 - $6.16 $600 - $948	154 New	154 $1,000
Q2 2019 Aug 14, 2019	SELL	$2.8 - $4.14 $117 - $173	-42 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$2.35 - $4.19 $1,005 - $1,793	-428 Reduced 91.06%	42 $0
Q4 2018 Feb 14, 2019	BUY	$2.17 - $3.8 $928 - $1,626	428 Added 1019.05%	470 $1,000
Q2 2018 Aug 14, 2018	SELL	$3.15 - $4.7 $48,714 - $72,685	-15,465 Reduced 99.73%	42 $0
Q1 2018 May 15, 2018	BUY	$2.5 - $4.45 $38,500 - $68,530	15,400 Added 14392.52%	15,507 $69,000
Q4 2017 Feb 14, 2018	BUY	$2.35 - $4.0 $251 - $428	107	107 $0

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.3M

Call Options Held

191K

Put Options Held

135K

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account